Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

NCT: NCT06257537 · COMPLETED

NCT IDNCT06257537
StatusCOMPLETED
Start Date2024-10-01
Completion2026-06-26
SponsorZetrOZ, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the ability of long-duration low intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over a 24-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of LITUS to improve joint function.

Frequently Asked Questions

What is Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis?

Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis is a clinical trial registered under NCT06257537. Current status: COMPLETED.

What is the status of NCT06257537?

The current status of NCT06257537 (Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis) is: COMPLETED.

When did Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis start?

Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis started on 2024-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.